Corundum Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Buy
7,778
+443
+6% +$103K 0.64% 33
2025
Q4
$1.52M Sell
7,335
-28
-0.4% -$5.54K 0.51% 38
2025
Q3
$1.37M Sell
7,363
-65
-0.9% -$11.1K 0.56% 38
2025
Q2
$1.13M Sell
7,428
-123
-2% -$18.9K 0.5% 50
2025
Q1
$1.25M Sell
7,551
-662
-8% -$104K 0.6% 37
2024
Q4
$1.19M Buy
8,213
+56
+0.7% +$8.68K 0.44% 61
2024
Q3
$1.32M Sell
8,157
-2,910
-26% -$464K 0.6% 32
2024
Q2
$1.62M Buy
11,067
+2,478
+29% +$369K 0.63% 43
2024
Q1
$1.36M Buy
8,589
+2,386
+38% +$380K 0.66% 30
2023
Q4
$972K Sell
6,203
-4,405
-42% -$675K 0.49% 48
2023
Q3
$1.65M Sell
10,608
-549
-5% -$90.6K 0.94% 21
2023
Q2
$1.85M Sell
11,157
-249
-2% -$40.2K 0.92% 20
2023
Q1
$1.77M Buy
11,406
+2,096
+23% +$338K 0.84% 28
2022
Q4
$1.65M Buy
9,310
+367
+4% +$63.4K 0.93% 26
2022
Q3
$1.46M Buy
8,943
+145
+2% +$24.5K 0.92% 23
2022
Q2
$1.56M Buy
8,798
+846
+11% +$151K 1.06% 20
2022
Q1
$1.41M Buy
7,952
+2,193
+38% +$373K 1.31% 20
2021
Q4
$985K Buy
5,759
+981
+21% +$161K 0.64% 27
2021
Q3
$772K Buy
4,778
+114
+2% +$19.4K 0.57% 29
2021
Q2
$768K Sell
4,664
-65
-1% -$10.8K 0.5% 28
2021
Q1
$777K Sell
4,729
-30
-0.6% -$4.85K 0.61% 25
2020
Q4
$749K Buy
4,759
+380
+9% +$56.1K 0.62% 23
2020
Q3
$652K Buy
4,379
+335
+8% +$49.6K 0.63% 23
2020
Q2
$569K Sell
4,044
-126
-3% -$18.4K 0.68% 18
2020
Q1
$547K Sell
4,170
-36
-0.9% -$5.11K 0.78% 18
2019
Q4
$614K Buy
4,206
+77
+2% +$10.4K 0.64% 20
2019
Q3
$534K Sell
4,129
-102
-2% -$13.4K 0.62% 20
2019
Q2
$589K Buy
4,231
+12
+0.3% +$1.66K 0.68% 20
2019
Q1
$590K Sell
4,219
-2,594
-38% -$347K 0.68% 18
2018
Q4
$879K Buy
+6,813
New +$950K 0.81% 20
2018
Q2
$494K Buy
4,072
+12
+0.3% +$1.5K 0.61% 20
2018
Q1
$520K Buy
4,060
+132
+3% +$17.8K 0.56% 18
2017
Q4
$549K Buy
3,928
+2
+0.1% +$279 0.59% 18
2017
Q3
$510 Buy
3,926
+409
+12% +$54.2K 0.54% 19
2017
Q2
$465K Buy
3,517
+121
+4% +$15.4K 1.03% 12
2017
Q1
$423K Hold
3,396
0.53% 14
2016
Q4
$391K Hold
3,396
0.57% 15
2016
Q3
$401K Buy
3,396
+169
+5% +$20.5K 0.65% 15
2016
Q2
$391K Sell
3,227
-1,181
-27% -$134K 0.6% 14
2016
Q1
$477K Buy
4,408
+1,170
+36% +$121K 1.26% 8
2015
Q4
$338K Buy
3,238
+410
+14% +$41.2K 1.01% 13
2015
Q3
$264K Buy
2,828
+568
+25% +$54.9K 0.94% 10
2015
Q2
$220K Buy
2,260
+84
+4% +$8.41K 0.78% 10
2015
Q1
$219K Buy
2,176
+19
+0.9% +$1.93K 0.74% 13
2014
Q4
$226K Sell
2,157
-19
-0.9% -$2K 0.91% 11
2014
Q3
$232K Sell
2,176
-33
-1% -$3.42K 1.1% 10
2014
Q2
$231K Buy
2,209
+101
+5% +$10.2K 1.08% 10
2014
Q1
$207K Sell
2,108
-101
-5% -$9.36K 1% 11
2013
Q4
$202K Buy
+2,209
New +$204K 0.95% 12

Other funds holding JNJ

Corundum Group's JNJ Position: Q1 2026 in Review

Corundum Group increased its Johnson & Johnson (JNJ) stake by 6% in Q1 2026, buying an estimated $103K and bringing the position to 7,778 shares worth $1.9M. The position accounts for 0.64% of the portfolio, ranked #33.

Corundum Group first reported a position in JNJ in Q4 2013 and has held it in 49 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Corundum Group held 7,778 shares of Johnson & Johnson worth $1.9M as of Q1 2026.
  • Corundum Group bought 443 Johnson & Johnson shares in Q1 2026, an estimated $103K.
  • Johnson & Johnson made up 0.64% of Corundum Group's portfolio in Q1 2026, its #33 holding.
  • Corundum Group first reported a position in Johnson & Johnson in Q4 2013 and has held it in 49 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Corundum Group's 13F filing for Q1 2026, filed 20 Apr 2026.